Accordingly, it has been reported that TIGIT, but not other immune checkpoint molecules such as CTLA-4 and PD-1, is associated with NK cell exhaustion in tumor-bearing mice and pts with CRC [28] and that the blockade of TIGIT restored NK cell antitumor activity [39,40]. This evidence concerns the gene CTLA4 and colorectal carcinoma.